News

Hawthorn Bancshares Delivers Strong Year-End Financial Performance

Hawthorn Bancshares Delivers Strong Year-End Financial Performance

Solid Financial Performance by Hawthorn Bancshares

Hawthorn Bancshares, Inc. (NASDAQ: HWBK), recognized for its legacy of financial services, has made headlines with its impressive net income of $4.6 million for the final quarter of 2024. This translates to earnings per diluted share of $0.66, ultimately contributing to an annual net income of $18.3 million, representing earnings of $2.61 per diluted share.

Highlights from the Fourth Quarter

In the fourth quarter, the net interest margin saw a notable increase to 3.55%, reflecting enhancements from its previous quarter of 3.36%. Additionally, the return on assets and equity registered at 1.00% and 12.49%, respectively, indicating solid operational efficiency.

Growth in Key Financial Metrics

The quarter marked a $14.8 million rise in investments, showcasing robust growth at 7.1% compared to the prior quarter. Deposits also grew, rising $29.7 million, a commendable 2.0% increase over the last quarter.

2024 Year-End Financial Overview

Looking back at the entire year, Hawthorn Bancshares experienced an increase of $1.0 million in net income, marking a significant gain from the $1.0 million in the previous year. This growth can be further illustrated by an elevation from $2.47 in earnings per share in 2023 to $2.61 in 2024.

Improvements in Financial Ratios

Hawthorn’s net interest margin (FTE) achieved a rate of 3.41%, while the return metrics remained stable with average assets and equity at 1.00% and 13.04% for the year.

Strategic Initiatives and Growth Plans

Brent Giles, the Chief Executive Officer of Hawthorn Bancshares, expressed satisfaction with the year’s earnings, noting the overall commitment to enhancing operational efficiency. The company's recent approval to open a new banking center in Overland Park marks another step forward in its growth strategy.

Operational Efficiencies and Cost Management

In a proactive move, Hawthorn managed to reduce non-interest expenses by 5.4%, ultimately leading to increased profitability during a time of vast challenges in the banking sector.

Looking Ahead

The bank capitalized on well-structured financial management, maintaining healthy levels with total risk-based capital at 14.79%. As of the close of the year, it reported strong credit quality with non-performing loans to total loans at merely 0.19%, a significant improvement over prior year metrics. Moreover, book value per share rose $2.03 to $21.36, reflecting the firm’s steadily augmenting asset base.

Progressive Changes in Investment Security

Investment securities also saw observable growth with a total of $223.8 million, demonstrating strategic long-term positioning in the market.

Conclusion

Overall, Hawthorn Bancshares has established a firm foundation for future growth with its impressive financial performance and strategic operational developments. Investors and stakeholders can look forward to sustainable growth as the bank continues to navigate and adapt to the changing economic landscape.

Frequently Asked Questions

What were the key financial results for Hawthorn Bancshares in 2024?

Hawthorn Bancshares reported a net income of $18.3 million, or $2.61 per diluted share, with significant improvements in various financial metrics.

What strategic initiatives are in place for Hawthorn Bancshares?

The company is set to open a new banking center in Overland Park, Kansas, emphasizing growth and operational synergies.

How did deposit levels change in 2024?

Total deposits increased by $29.7 million, or 2.0%, compared to the previous quarter, showcasing stable customer trust and engagement.

What does the future hold for Hawthorn Bancshares?

With strong financial performance and effective management strategies, Hawthorn is poised for continued growth in a dynamic financial landscape.

How has credit quality been managed?

The bank maintained a robust credit quality with non-performing loans to total loans ratio at 0.19%, indicating effective risk management strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading

Top 5 Most Recently Viewed Articles

Hofseth BioCare ASA Secures Funding Through Private Placement

Updated Category News Views 216

Hofseth BioCare ASA Successfully Completes a Private Placement Hofseth BioCare ASA, often referred to as HBC, has recently completed a significant private placement aimed at enhancing its growth capital and strengthening its corporate balance sheet. This strategic move is set to fund the company's ongoing developments and initiatives effectively. The Details of the...

Continue Reading
Prosus N.V. Announces Limit for Tender Offer Notes

Updated Category News Views 78

The Brass Tacks of Prosus's Recent Move Today, Prosus N.V. put a definitive cap on its cash tender offer, inviting investors to sell back their notes due in 2027. What’s happening under this financial tablecloth? We’re diving into a U.S.$1,035,854,000 cap on the tendered notes—shaved down from their new senior notes total of U.S.$1,650,000,000. Decoding the Offer:...

Continue Reading
Growth Potential of the Asia Pacific Conference Room Solutions Market

Updated Category News Views 119

Understanding the Growth in the Asia Pacific Conference Room Solutions Market The Asia Pacific conference room solutions market is on a remarkable growth trajectory, with valuations surging from US$ 300.08 million in 2023 to a stunning US$ 1,922.25 million projected by 2032, at a compound annual growth rate (CAGR) of 23.79%. This surge can be attributed to several...

Continue Reading
BexBack Launches High-Leverage Trading with Exciting Bonuses

Updated Category News Views 176

Exciting New Trading Features from BexBack BexBack, a leading cryptocurrency exchange platform, is thrilled to reveal its latest trading enhancements, designed for traders eager to amplify their market position. These innovative features are now accessible to users across the globe, marking a significant step in meeting the soaring demand for high-leverage crypto trading....

Continue Reading
NexGen Health Achieves Milestone with Stellar Customer Reviews

Updated Category News Views 200

NexGen Health Celebrate Customer Satisfaction Milestone Leading Silicon Valley wellness clinic's exceptional patient reviews emphasize their commitment to cutting-edge IV therapy, personalized care, and innovative health solutions. NexGen Health, Silicon Valley's premiere wellness and anti-aging clinic, proudly announces a significant customer satisfaction milestone with...

Continue Reading